The association between Hemoglobin A1c and complications among individuals with diabetes and severe chronic kidney disease
Kofod DH, Carlson N, Almdal TP, et al.
Diabetes Care. 2025:dc250339.
Leggi
Breaking news
The health economics of insulin therapy: how do we address the rising demands, costs, inequalities and barriers to achieving optimal outcomes
McEwan P, Evans M
Diabetes Obes Metab. Pub. online 4 Jun 2025.
Leggi
Glucagon-like peptide-1 receptor agonists and gastrointestinal cancer risk in individuals with type 2 diabetes
Kuo CC, Chuang MH, Li CH, et al.
Diabetologia. Pub. online 5 Jun 2025.
Leggi
Income and severe hypoglycemia in type 2 diabetes
Kim M, Han K, Lee K, et al.
JAMA Netw Open. 2025;8(6):e2513293.
Leggi
Biomarkers in diabetic nephropathy: a comprehensive review of their role in early detection and disease progression monitoring
Wani ZA, Ahmed S, Saleh A, et al.
Diabetes Res Clin Pract. 2025:112292.
Leggi
AIFA: Ridurre l’impatto ambientale dei farmaci: in un Report le misure proposte dal gruppo di lavoro europeo
6 giugno 2025
Leggi
EMA: New guideline on inclusion of pregnant and breastfeeding individuals in clinical trials
4 giugno 2025
Leggi
EMA: PRAC concludes eye condition NAION is a very rare side effect of semaglutide medicines Ozempic, Rybelsus and Wegovy. Treatment with semaglutide should be stopped if NAION occurs 6 giugno 2025
6 giugno 2025
Leggi
Kidney disease: the forgotten legacy of type 1 diabetes
Thomas MC, Zoungas S, Hanssen NMJ, et al.
Diabetes Care. 2025:dci250028.
Leggi